Investor Presentations
Recent Presentation
Events
Upcoming Events
Past Events & Webcast Recordings
MST Access Rare Diseases, Rich Returns Forum
June 22, 2023
Click here for webcast
Share Series Monday Management Update
May 22, 2023
Click here for recording
ShareCafe Small Cap “Hidden Gems” Webinar
March 9, 2023
Click here for presentation
Sachs Associates 6th Annual Neuroscience Innovation Forum
January 3, 2023
Switzer Small & Micro Cap Investor Day
July 4, 2022 – 9 am-12:30 pm AEST
Click here to watch the presentation
VirtualInvestorConferences Life Sciences Investor Forum
June 23, 2022 – 8:00 a.m. Pacific Time / 11:00 a.m. Eastern Time
Click here for webcast
GCFF Virtual Conference 2022 – Investing in Healthcare
June 16, 2022 – 8:30 a.m. Pacific Time
Click here for webcast in English
Click here for webcast in Chinese
Benchmark Healthcare House Call Conference
June 2, 2022
American Academy of Neurology
April 2-7, 2022
Sachs Neuroscience Innovation Forum
March 22-23, 2022
Roth Conference
March 14-15, 2022
HC Wainwright Conference
January 10, 2022
Warning: getimagesize(https://alteritytherapeutics.com/wp-content/uploads/Appendix 4C – Q2 FY22 Quarterly Cash Flow Report - 27 January 2022): Failed to open stream: HTTP request failed! HTTP/1.1 400 Bad Request in /var/www/wp-content/plugins/document-gallery/inc/thumbers/class-abstract-thumber.php on line 135
Investor Presentations
Recent Presentation
| June 22, 2023 | Corporate Presentation June 2023 | 4 MB | |
| May 26, 2023 | Corporate Presentation May 2023 | 4 MB |
Archive
2022
| October 28, 2022 | Appendix 4C – Q1 FY 2023 Quarterly Cash Flow Report – 28 October 2022 | 662 KB | |
| October 28, 2022 | Appendix 4C – Q4 FY 2022 Quarterly Cash Flow Report – 22 July 2022 | 649 KB | |
| September 1, 2022 | Form 20-F 2022 | 850 KB | |
| September 1, 2022 | ATH Annual Report 2022 | 2 MB | |
| April 29, 2022 | Appendix 4C – Q3 FY 2022 Quarterly Cash Flow Report – 29 April 2022 | 1 MB | |
| January 27, 2022 | Appendix 4C – Q2 FY22 Quarterly Cash Flow Report – 27 January 2022 | 422 KB |
2021
| June 24, 2022 | Half Year Financial Report Period to 31 Dec 2021 | 388 KB | |
| October 29, 2021 | Appendix 4C – September 2021 | 2 MB | |
| September 3, 2021 | Form 20-F 2021 | 776 KB | |
| September 1, 2021 | Annual Report 2021 | 3 MB | |
| July 30, 2021 | Appendix 4C-June 2021 | 411 KB | |
| April 29, 2021 | Appendix 4C – March 2021 | 418 KB | |
| February 25, 2021 | Appendix 4D 2020 | 374 KB |
2020
| January 29, 2021 | Appendix 4C- December 2020 | 339 KB | |
| October 30, 2020 | Appendix 4C- September 2020 | 354 KB | |
| September 16, 2020 | Form 20-F 2020 | 2 MB | |
| September 9, 2020 | Appendix 4G Ended 30 June 2020 | 374 KB | |
| September 9, 2020 | Annual Report 2020 | 2 MB | |
| August 31, 2020 | Appendix 4E Year ended 30 June 2020 | 454 KB | |
| July 30, 2020 | Appendix 4C – June 2020 | 384 KB | |
| April 30, 2020 | Appendix 4C – March 2020 | 346 KB | |
| February 28, 2020 | Form 6-K Feb 2020 | 233 KB | |
| February 28, 2020 | Appendix 4D 2019 | 410 KB | |
| January 31, 2020 | Appendix 4C – December 2019 | 372 KB |
2019
| October 30, 2019 | Appendix 4C – September 2019 | 346 KB | |
| September 2, 2019 | Form 20-F 2019 | 828 KB | |
| August 30, 2019 | Appendix 4G FY Ended 2019_06_30 | 341 KB | |
| August 30, 2019 | Annual Report 2019 | 1 MB | |
| August 1, 2019 | Appendix 4C – June 2019 | 151 KB | |
| May 13, 2019 | Form-6-K-2019_03_01 | 400 KB | |
| April 16, 2019 | Appendix 4C – Mar 2019 | 161 KB | |
| February 28, 2019 | Form 6-K – Mar 2019 | 400 KB | |
| February 28, 2019 | Appendix 4D 2018 | 217 KB | |
| January 31, 2019 | Appendix 4C – Dec 2018 | 234 KB |
2018
| May 13, 2019 | Form 6-K Feb 2018 | 148 KB | |
| October 30, 2018 | Appendix 4C – Sept 2018 | 170 KB | |
| September 3, 2018 | Form 20F – 2018 | 2 MB | |
| August 31, 2018 | Appendix 4G FY Ended 2018_06_30 | 123 KB | |
| August 31, 2018 | Annual Report 2018 | 2 MB | |
| July 30, 2018 | Appendix 4C – Jun 2018 | 262 KB | |
| May 7, 2018 | Appendix 4C – Mar 2018 | 263 KB | |
| March 4, 2018 | Form 6-K Feb 2018 | 148 KB |
Receive news from Alterity Therapeutics
